clinical trials

Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.

It can be easy to get your hopes up about exciting new research or alternative approaches to cancer treatment. Here's an insider's guide for figuring out which ones are worth your time.

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.